FDA approves Chinese drug Lian Hua Qing Wen for mild COVID-19
Maris Federez • August 13, 2020 • 397
MANILA, Philippines — The Food and Drug Administration (FDA) has approved a traditional Chinese drug for the treatment of mild coronavirus disease 2019 (COVID-19).
According to the Certificate of Product Registration released by the FDA, Lian Hua Qing Wen “has been found to conform with the requirements and standards for marketing authorization for pharmaceutical products per existing regulations in force as of date hereof.”
Lian Hua Qing Wen, produced by traditional Chinese medicine manufacturer Shijiazhuang Yiling Pharmaceutical Co. Ltd., was approved for use in the Philippines last Friday (August 7).
In a statement, the Chinese Embassy in the Philippines said the approval was a welcome development for them as “this marks an important progress in the entry of TCM products into the Philippine market.”
The statement added that the said medicine is an approved COVID-19 treatment for mild and moderate cases in China.
The embassy added that the drug has also been approved in Hong Kong, Macau, Brazil, Indonesia, Canada, Mozambique, Romania, Thailand, Ecuador, Singapore, and Laos.
“It is our sincere hope that its entrance into the Philippine market will contribute to the fight against the spread of COVID-19 in this country and help the patients with mild and moderate symptoms recover,” it added.
The embassy, however, advised consumers to purchase and consume authentic traditional Chinese medicine only.
The Embassy also hopes that “TCM would play a bigger role to support the efforts of the Philippine government and its people to fight against COVID-19 until the final victory.” — /mbmf
MANILA, Philippines — The Inter-Agency Task Force (IATF) is now requiring facility-based isolation for confirmed asymptomatic and mild coronavirus disease (COVID-19) cases through IATF Resolution 74.
The new policy however, exempts patients who are considered vulnerable or having comorbidities and their home meets the conditions specified in the Department of Health (DOH) and the Department of the Interior and Local Government (DILG) Joint Administrative Order 2020-0001.
Likewise, another exception is when the Ligtas COVID-19 Centers within the region are fully occupied and the local government unit does not have sufficient isolation facilities.
MANILA, Philippines – The country’s Food and Drug Administration (FDA) on Friday said the approval of a vaccine against novel coronavirus disease may be possible in April 2021.
During a virtual press briefing, FDA Director General Eric Domingo said this is “the best case scenario” if clinical trials are completed on schedule.
“If clinical trials are completed by December or January, and a company would file an application with FDA, it’s possible that by April 2021 we will have an approved vaccine,” he said.
“Talagang best case scenario yun, meaning yung three to six months, magiging three months; assuming that they will complete all their analysis and submitted immediately to FDA,” he added.
In the same briefing, Department of Science and Technology (DOST) Secretary Fortunato dela Peña said the time period of three to six months is the experts’ estimate on the completion of Phase III clinical trials for vaccine candidates.
“When they say 3-6 months, we prefer to use the longer forecast in our estimates. That would indicate in that period they would have finished clinical trials and probably already submitted to FDA their application and results of their trials,” he said.
Dela Peña said the World Health Organization (WHO) is set to release its list of selected vaccines and protocols in October and that the fastest that they can start the clinical trials will be in the last quarter of 2020.
“The vaccine trials according to experts will range from 3 to 6 months. I think the very early forecast that we have of second quarter 2021 is still the best forecast we can give,” he said.
The DOST said the Philippines is currently negotiating with 17 vaccine developers from other countries and six of them have already signed confidentiality disclosure agreements that would allow the sharing of their earlier trial results.
Among the six vaccine developers are Russia’s Gamaleya Research Institute and China’s Sinovac.
The FDA earlier promised it would expedite the approval procedures but assured that no steps will be skipped to ensure public’s health and safety. – RRD (with details from Correspondent Aiko Miguel)
MANILA, Philippines — Iloilo City has been placed under modified enhanced community quarantine (MECQ) effective September 25 until October 9 due to the increasing number of coronavirus disease (COVID-19) cases in the city.
According to Presidential Spokesperson Harry Roque the new measure is based on the issued Inter-Agency Task Force (IATF) Resolution 74 which also requires facility-based isolation for confirmed asymptomatic and mild COVID-19 cases.
However, the resolution exempts patients who are considered vulnerable or having comorbidities as confirmed by the local health officer.
Another exception would be when the Ligtas COVID-19 Centers within the region are fully occupied and the local government unit does not have sufficient isolation facilities.
On Tuesday (September 22), 33 employees of the Iloilo City Hall tested positive for COVID-19 prompting the three-day temporary closure of the establishment beginning Wednesday (September 23) as declared by Mayor Jerry Treñas in Executive Order No. 215-A.
Prior to that, 13 barangays in the city were placed under total lockdown due to the increase in community transmission of COVID-19.
UNTV is a major TV broadcast network with 24-hour programming. An Ultra High Frequency station with strong brand content that appeal to everyone, UNTV is one of the most trusted and successful Philippine networks that guarantees wholesome and quality viewing experience.